SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-012867
Filing Date
2017-11-13
Accepted
2017-11-13 13:59:51
Documents
49
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 698484
2 ex31-1.htm EX-31.1 17571
3 ex31-2.htm EX-31.2 16468
4 ex32-1.htm EX-32.1 7666
5 ex32-2.htm EX-32.2 7658
  Complete submission text file 0001493152-17-012867.txt   3264546

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE prph-20170930.xml EX-101.INS 411484
7 XBRL SCHEMA FILE prph-20170930.xsd EX-101.SCH 43332
8 XBRL CALCULATION FILE prph-20170930_cal.xml EX-101.CAL 56247
9 XBRL DEFINITION FILE prph-20170930_def.xml EX-101.DEF 143051
10 XBRL LABEL FILE prph-20170930_lab.xml EX-101.LAB 315341
11 XBRL PRESENTATION FILE prph-20170930_pre.xml EX-101.PRE 220412
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21617 | Film No.: 171195122
SIC: 2834 Pharmaceutical Preparations